Vir Biotechnology and Alnylam expand alliance for Covid-19 drugs
Vir Biotechnology and Alnylam Pharmaceuticals have expanded their multi-target infectious diseases alliance to include up...
Read More...
Focus:
North-america
-
![FluGen, Bharat Biotech and UW–Madison partner on Covid-19 vaccine]()
FluGen, Bharat Biotech and UW–Madison partner on Covid-19 vaccine
Vaccine development companies FluGen and Bharat Biotech have partnered with the University of Wisconsin–Madison to...
Read More...
-
![Kite licences Teneobio multiple myeloma targeting antibodies]()
Kite licences Teneobio’s multiple myeloma targeting antibodies
Gilead unit Kite has signed a licence and collaboration agreement with Teneobio for sole rights...
Read More...
-
![types of covid-19 test]()
Different paths to the same destination: screening for Covid-19
At present, polymerise chain reaction (PCR) and antibody testing are the dominant ways that global...
Read More...
-
![Covid-19 vaccine candidate yields promising data in mice]()
Covid-19 vaccine candidate yields promising data in mice
Researchers at University of Pittsburgh School of Medicine in the US have reported encouraging results...
Read More...
-
![Amgen and Adaptive Biotechnologies to develop Covid-19 drug]()
Amgen and Adaptive Biotechnologies to develop Covid-19 drug
Amgen has partnered with Adaptive Biotechnologies to develop a drug candidate that could prevent and...
Read More...
-
![orthopaedics; covid-19]()
Orthopaedics markets experience unsteady growth due to Covid-19
As hospitals are overwhelmed by Covid-19 patients, elective surgeries are cancelled or indefinitely delayed. The majority of orthopaedics procedures, such…
Read More…
-
![Covid-19 cases]()
Global confirmed Covid-19 cases exceed one million
The Covid-19 cases have crossed one million globally, with the pandemic being responsible for more...
Read More...
-
![Top 10 coronavirus countries]()
COVID-19 coronavirus: Top ten most-affected countries
One Asian country and seven European countries are among the ten most affected list of...
Read More...
-
![]()
Citius licences Novellus’ stem cell therapy for Covid-19-related ARDS
Citius Pharmaceuticals has entered an exclusive six-month option agreement to licence a stem cell therapy...
Read More...
Close
Close
Close
Go Top